http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100715939-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-539 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100715939-B1 |
| titleOfInvention | Drug addiction treatment |
| abstract | The present invention relates to a drug addiction therapeutic agent comprising a golden extract, betaine or a mixture thereof as an active ingredient and a pharmaceutically acceptable carrier. The drug addiction therapeutic agent of the present invention can effectively suppress the drug dependence formed by the administration of narcotic analgesics, and thus can be widely used to solve the side effects of safe and effective narcotic analgesics.n n n n Drug addiction, golden extract, betaine |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150044623-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170008491-A |
| priorityDate | 2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.